The Evolution of Screening Tools for Prostate Cancer

The utility of prostate-specific antigen (PSA) screening for prostate cancer detection is impacted by detection of cancers with low risk of mortality. Editorialist Jeffrey J. Tosoian, MD, MPH, discusses a pragmatic approach to prostate cancer screening with JAMA Deputy Editor Mary L. (Nora) Disis, MD.

Related Content:

A Pragmatic Approach to Prostate Cancer Screening

Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI

Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality

Podcast was originally published on April 6, 2024.

---------------------------------------------------------------------------------
Follow JAMA Author Interviews on:

---------------------------------------------------------------------------------
For more from JAMA

Follow the JAMA Network